Thus, in a case–control study within the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial, the relationship of prediagnostic serum levels of adiponectin, leptin, and visfatin with postmenopausal endometrial cancer risk was prospectively evaluated 30. Here, ADIPOQ is linked to ovarian cancer.